Total raised
$82.3M
Last: Series D 2024-08
Stage
Series D
Founded
2008
Headcount
68
HQ
Netanya
Sector
Health Tech & Life Sciences
About
ART Medical developed an all-in-one solution designed to detect and prevent feeding-related complications while ensuring optimal patient nutrition in order to accelerate patient recovery. The company mission is to bring critical care into the 21st century and save lives by preventing ICU-acquired complications, such as aspiration pneumonia, ventilator-associated events, malnutrition and acute kidney injury (AKI).
smART+ is a sensor-based feeding tube designed to detect and prevent reflux events.
The company's technology has received FDA approval. The company continues to expand its technology and work on clinical validations.
Funding history · 5 rounds · $82.3M total
2024-08
Series D
$20.5M
2022-01
Series C
$32.8M
2017-06
Series B
$20.0M
2016-03
Series A
$3.5M
2012-06
Seed
$5.5M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife SupportDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceSensing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
real-timemonitoringgastroenterologyhospitalsmedical-devicespreventionrespiratoryfeedingsensorsdoctorsartificial-intelligencedigital-healthcarealgorithmspersonalization3d-imaging